TABLE 4.
Current Indications for Which REBOA Is Used Among the Military Systems and Expert Panel Responses Regarding the Indications and Contraindications for REBOA Use in Military Environments
| Current Use of REBOA Among Military Systems | Panel Members Confirming (n) | |
|---|---|---|
| Neck injury | 1/21; 4.8% | |
| Junctional injury | 15/21; 71.4% | |
| Penetrating thoracic injury | 3/21; 14.3% | |
| Blunt thoracic injury | 4/21; 19.1% | |
| Penetrating abdominal injury | 18/21; 85.7% | |
| Blunt abdominal injury | 17/21; 81.0% | |
| Multiple bleeding sites | 7/21; 33.3% | |
| Traumatic cardiac arrest | 11/21; 52.4% | |
| Other: all necessary injuries/no differentiation specified | 2/21; 9.5% |
| Expert panel consensus | Panel members agreeing (n) | Consensus reached |
|---|---|---|
| Use of REBOA indicated in military environments* | ||
| Junctional groin injury | 25/27; 92.6% | Yes |
| Junctional axillary injury | 14/26; 53.9% | No |
| Pelvic injury | 26/27; 96.3% | Yes |
| Traumatic cardiac arrest | 20/27; 74.1% | Yes |
| Use of REBOA not contraindicated in military environments* | ||
| Multiple major bleeding sites | 24/27; 88.9% | Yes |
| Use of REBOA contraindicated in military environments | ||
| Solitary major neck injury | 23/27; 85.2% | Yes |
| ≥1 major thoracoabdominal bleeding sites and a major neck injury | 16/27; 59.3% | No |
| ≥1 major bleeding site below the diaphragm and a major neck injury | 18/27; 66.7% | No |
| Blunt thoracic injury | 17/27; 63.0% | No |
| Penetrating chest injury | 16/27; 59.3% | No |
*Among hemodynamic unstable patients and assuming that surgical care will be available within an acceptable timeframe.